Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition)-Reference-Cited by-同舟云学术

Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition)

Published:2017-07-01 Issue:9 Volume:24 Page:648-666
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Kakehi Yoshiyuki¹,Sugimoto Mikio¹,Taoka Rikiya¹,

Affiliation:

1. Department of Urology; Faculty of Medicine; Kagawa University; Kagawa Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13380/fullpdf

Reference159 articles.

1. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

2. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

3. International Agency for Research on Cancer GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 http://globocan.iarc.fr/Default.aspx

4. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethinic group in England 2008-2010;Lloyd;BMC Med.,2015

5. Temporal trends and racial disparities in global prostate cancer prevalence;Rebbeck;Can. J. Urol.,2014

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA PET/CT imaging and its application to prostate cancer treatment;Japanese Journal of Radiology;2024-09-03

2. Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy;International Journal of Urology;2024-08-23

3. Editorial Comment on Japanese clinical practice guidelines for prostate cancer 2023;International Journal of Urology;2024-08-14

4. PSA screening for prostate cancer in the United States: 30 years of controversy;Journal of Public Health Policy;2024-08-02

5. Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan;International Journal of Clinical Oncology;2024-08-01